Last reviewed · How we verify
NCT05545462
Comparison Of Doxycycline And Common Salt For Treatment Of Umbilical Granuloma: A Randomised Control Trial
NA trial testing Doxycyclin in Umbilical Granuloma in 196 participants. Completed in 30 September 2021.
30 September 2021
Quick facts
| Lead sponsor | Shaheed Zulfiqar Ali Bhutto Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 196 |
| Start date | 1 October 2020 |
| Primary completion | 30 September 2021 |
| Estimated completion | 30 September 2021 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Doxycyclin — full drug profile →
- COMMON SALT
Conditions studied
- Umbilical Granuloma — all drugs for Umbilical Granuloma →
Sponsor
Shaheed Zulfiqar Ali Bhutto Medical University
Who can join
Adults 1 Month to 1, any sex, with Umbilical Granuloma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
it is the study for the disease called umbilical granuloma to look for the better treatment option which can be performed by healthcare physicians and local nurses and even parents
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05545462
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Doxycyclin
Trials testing the same drug.
- NCT06452394 — NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline · Phase 2 · recruiting
- NCT05972772 — Rickettsia Clearance Study · Phase 2, PHASE3 · recruiting
- NCT06329882 — Doxycycline in Type II Diabetes · Phase 1, PHASE2 · recruiting
- NCT05897034 — Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men · Phase 2, PHASE3 · not yet recruiting
- NCT06520007 — Comparison Between Continuous and Pulsed Oral Doxycycline Treatment Protocols for Refractory Meibomian Gland Dysfunction · completed
Other Shaheed Zulfiqar Ali Bhutto Medical University trials
Trials by the same sponsor.
- NCT06525844 — Regenerative Endodontic Therapy in Cases of Irreversible Pulpitis · NA · recruiting
- NCT06176430 — Comparison of Twice Weekly Versus Daily Iron Therapy in Treating Anemia in Children With Cerebral Palsy · Phase 4 · unknown
- NCT06234020 — Frequency of Vertebrospinal Anomalies in Patients Presenting With Anorectal Malformations · completed
- NCT06323642 — Role of Probiotics as Adjunct Therapy Along With Standard Care in Decreasing Hospital Stay and Improving Symptoms in Ped · NA · unknown
- NCT06164158 — Role of Procedural Videos in Teaching the Surgery Residents · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05545462 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shaheed Zulfiqar Ali Bhutto Medical University
- Last refreshed: 19 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05545462.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing